Search results
Moderna’s long Covid plan
Politico· 2 days agoEven so: Rizkalla said Moderna...immune response to the virus. Rizkalla declined to offer any timeline for Moderna’s development efforts ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoThe European Medicines Agency made the same recommendation. In an interview with Barron’s in early...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 3 days agoBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 1 day agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Ayahuasca, Abortion And Brain Worms At An RFK Jr. Rally In Colorado
HuffPost via Yahoo News· 1 day agoKennedy’s entourage included former Pussycat Dolls member Jessica Sutta, a self-described “vaccine...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 5 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoIt accused them of using its patented mRNA technology in their vaccine, Comirnaty. The two companies...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 1 day agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 2 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 3 days agoIndeed, the company has climbed 44% so far this year as one of the big winners of 2024’s bull market. Vaccine stocks have been on the climb this week amid reports of new human ...
